Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 715

1.

Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection.

Itoh S, Yoshizumi T, Sakata K, Motomura T, Mano Y, Toshima T, Harimoto N, Harada N, Ikegami T, Soejima Y, Kusaba R, Kamishima T, Nishie A, Maehara Y.

J Gastrointest Surg. 2018 Oct 8. doi: 10.1007/s11605-018-3993-5. [Epub ahead of print]

PMID:
30298420
2.

Patient Dose Comparison for Intraoperative Imaging Devices Used in Orthopaedic Lumbar Spinal Surgery.

Moore B, Womack KR, Nguyen G, Foster N, Richardson W, Yoshizumi T.

J Am Acad Orthop Surg Glob Res Rev. 2018 Jul 24;2(7):e030. doi: 10.5435/JAAOSGlobal-D-18-00030. eCollection 2018 Jul.

3.

Promising method for management of venoarterial extracorporeal membrane oxygenation: A case of severe heart failure successfully stabilized by "high-flow/vasodilation method".

Kondo T, Sawamura A, Okumura T, Kano N, Morimoto R, Watanabe N, Hiraiwa H, Kuwayama T, Sugiura Y, Haga T, Yamaguchi S, Fukaya K, Yokoi T, Fujimoto K, Mutsuga M, Yoshizumi T, Matsuda N, Usui A, Murohara T.

J Cardiol Cases. 2018 Jun 14;18(2):81-84. doi: 10.1016/j.jccase.2018.05.002. eCollection 2018 Aug.

4.

A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.

Watanabe A, Harimoto N, Araki K, Yoshizumi T, Arima K, Yamashita Y, Baba H, Tetsuya H, Kuwano H, Shirabe K.

J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250. [Epub ahead of print]

PMID:
30261101
5.

Strategy of Cardiovascular Surgery for Patients With Dementia as Evaluated by Mini-Mental State Examination.

Terazawa S, Oshima H, Narita Y, Fujimoto K, Mutsuga M, Tokuda Y, Yoshizumi T, Ito H, Uchida W, Usui A.

Circ J. 2018 Sep 27. doi: 10.1253/circj.CJ-18-0312. [Epub ahead of print]

6.

Feasibility of all-in-one venoplasty with venous cuff using opened round ligament for right lobe graft in living donor liver transplantation.

Toshima T, Yoshizumi T, Simokawa M, Ikegami T, Harada N, Itoh S, Mano Y, Motomura T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Sep 19. doi: 10.1002/lt.25339. [Epub ahead of print]

PMID:
30230163
7.

Delayed C5 Palsy After Anterior Cervical Decompression Surgery: Preoperative Foraminal Stenosis and Postoperative Spinal Cord Shift Increase the Risk of Palsy.

Takase H, Murata H, Sato M, Tanaka T, Miyazaki R, Yoshizumi T, Tateishi K, Kawahara N, Yamamoto T.

World Neurosurg. 2018 Sep 12. pii: S1878-8750(18)32049-7. doi: 10.1016/j.wneu.2018.08.240. [Epub ahead of print]

PMID:
30218802
8.

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.

Okabe H, Yoshizumi T, Yamashita YI, Imai K, Hayashi H, Nakagawa S, Itoh S, Harimoto N, Ikegami T, Uchiyama H, Beppu T, Aishima S, Shirabe K, Baba H, Maehara Y.

PLoS One. 2018 Sep 14;13(9):e0203856. doi: 10.1371/journal.pone.0203856. eCollection 2018.

9.

Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation.

Harada N, Yoshizumi T, Ikegami T, Itoh S, Furusho N, Kato M, Shimoda S, Fukuhara T, Soejima Y, Maehara Y.

Anticancer Res. 2018 Sep;38(9):5513-5520. doi: 10.21873/anticanres.12885.

PMID:
30194210
10.

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature.

Iseda N, Yoshizumi T, Toshima T, Morinaga A, Tomiyama T, Takahashi J, Motomura T, Mano Y, Itoh S, Harada N, Ikegami T, Soejima Y.

Surg Case Rep. 2018 Aug 29;4(1):101. doi: 10.1186/s40792-018-0505-5.

11.

Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial.

Belley MD, Craciunescu O, Chang Z, Langloss BW, Stanton IN, Yoshizumi TT, Therien MJ, Chino JP.

Brachytherapy. 2018 Aug 24. pii: S1538-4721(18)30427-6. doi: 10.1016/j.brachy.2018.07.014. [Epub ahead of print]

PMID:
30150015
12.

Usability of Intraoperative Fluorescence Imaging with Indocyanine Green During Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage.

Yoshiya S, Minagawa R, Kamo K, Kasai M, Taketani K, Yukaya T, Kimura Y, Koga T, Kai M, Kajiyama K, Yoshizumi T.

World J Surg. 2018 Aug 13. doi: 10.1007/s00268-018-4760-1. [Epub ahead of print]

PMID:
30105635
13.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.

Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y, Uchiyama H, Utsunomiya T, Kajiyama K, Kimura K, Kishihara F, Sugimachi K, Tsujita E, Ninomiya M, Fukuzawa K, Maeda T, Shirabe K, Maehara Y.

Ann Surg Oncol. 2018 Oct;25(11):3316-3323. doi: 10.1245/s10434-018-6672-6. Epub 2018 Jul 26.

PMID:
30051372
14.

A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach.

Watanabe H, Asayama Y, Nishie A, Ishigami K, Ushijima Y, Okamoto D, Fujita N, Yoshizumi T, Oda Y, Honda H.

Radiol Case Rep. 2018 Apr 18;13(3):689-692. doi: 10.1016/j.radcr.2018.03.022. eCollection 2018 Jun.

15.

Evaluating Lens Dose Reduction in Pediatric Neuroradiology Examinations Using Automated Kilovoltage Selection Software.

Raudabaugh J, Smith AK, Moore B, Ramirez-Giraldo JC, Januzis N, Yoshizumi T.

AJR Am J Roentgenol. 2018 Sep;211(3):635-640. doi: 10.2214/AJR.17.19089. Epub 2018 Jun 27.

PMID:
29949420
16.

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature.

Yugawa K, Yoshizumi T, Harada N, Motomura T, Harimoto N, Itoh S, Ikegami T, Soejima Y, Maehara Y.

Surg Case Rep. 2018 Jun 19;4(1):60. doi: 10.1186/s40792-018-0468-6.

17.

Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation.

Imai D, Yoshizumi T, Sakata K, Ikegami T, Itoh S, Harada N, Motomura T, Toshima T, Mano Y, Soejima Y, Maehara Y.

Transplantation. 2018 Sep;102(9):e382-e391. doi: 10.1097/TP.0000000000002324.

PMID:
29912047
18.

Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.

Muto J, Sugiyama M, Shirabe K, Mukaide M, Kirikae-Muto I, Ikegami T, Yoshizumi T, Yamashita YI, Maehara Y, Mizokami M.

Ann Hepatol. 2018 July - August ,;17(4):596-603. doi: 10.5604/01.3001.0012.0927.

19.

Lymphocyte-to-Monocyte Ratio is a Predictor of Survival after Liver Transplantation for Hepatocellular Carcinoma.

Mano Y, Yoshizumi T, Yugawa K, Ohira M, Motomura T, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Jun 12. doi: 10.1002/lt.25204. [Epub ahead of print]

PMID:
29893464
20.

Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Yamashita YI, Imai K, Kaida T, Yamao T, Tsukamoto M, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Yoshizumi T, Ikeda T, Maehara Y, Baba H.

Surg Endosc. 2018 Jun 5. doi: 10.1007/s00464-018-6264-3. [Epub ahead of print]

PMID:
29872945
21.

Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.

Yamashita YI, Imai K, Yusa T, Nakao Y, Kitano Y, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Yoshizumi T, Aishima S, Maehara Y, Baba H.

Ann Gastroenterol Surg. 2018 Jan 8;2(3):197-203. doi: 10.1002/ags3.12057. eCollection 2018 May.

22.

NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population.

Nishida N, Aiba Y, Hitomi Y, Kawashima M, Kojima K, Kawai Y, Ueno K, Nakamura H, Yamashiki N, Tanaka T, Tamura S, Mori A, Yagi S, Soejima Y, Yoshizumi T, Takatsuki M, Tanaka A, Harada K, Shimoda S, Komori A, Eguchi S, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2018 May 23;8(1):8071. doi: 10.1038/s41598-018-26369-6.

23.

Liver-enriched transcription factor expression relates to chronic hepatic failure in humans.

Guzman-Lepe J, Cervantes-Alvarez E, Collin de l'Hortet A, Wang Y, Mars WM, Oda Y, Bekki Y, Shimokawa M, Wang H, Yoshizumi T, Maehara Y, Bell A, Fox IJ, Takeishi K, Soto-Gutierrez A.

Hepatol Commun. 2018 Mar 23;2(5):582-594. doi: 10.1002/hep4.1172. eCollection 2018 May.

24.

AtPep3 is a hormone-like peptide that plays a role in the salinity stress tolerance of plants.

Nakaminami K, Okamoto M, Higuchi-Takeuchi M, Yoshizumi T, Yamaguchi Y, Fukao Y, Shimizu M, Ohashi C, Tanaka M, Matsui M, Shinozaki K, Seki M, Hanada K.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):5810-5815. doi: 10.1073/pnas.1719491115. Epub 2018 May 14.

PMID:
29760074
25.

Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial.

Kaido T, Shinoda M, Inomata Y, Yagi T, Akamatsu N, Takada Y, Ohdan H, Shimamura T, Ogura Y, Eguchi S, Eguchi H, Ogata S, Yoshizumi T, Ikegami T, Yamamoto M, Morita S, Uemoto S.

Nutrition. 2018 Oct;54:68-75. doi: 10.1016/j.nut.2018.02.022. Epub 2018 Mar 20.

PMID:
29747091
26.

Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.

Strnadel J, Carromeu C, Bardy C, Navarro M, Platoshyn O, Glud AN, Marsala S, Kafka J, Miyanohara A, Kato T Jr, Tadokoro T, Hefferan MP, Kamizato K, Yoshizumi T, Juhas S, Juhasova J, Ho CS, Kheradmand T, Chen P, Bohaciakova D, Hruska-Plochan M, Todd AJ, Driscoll SP, Glenn TD, Pfaff SL, Klima J, Ciacci J, Curtis E, Gage FH, Bui J, Yamada K, Muotri AR, Marsala M.

Sci Transl Med. 2018 May 9;10(440). pii: eaam6651. doi: 10.1126/scitranslmed.aam6651.

PMID:
29743351
27.

Repression of Nitrogen Starvation Responses by Members of the Arabidopsis GARP-Type Transcription Factor NIGT1/HRS1 Subfamily.

Kiba T, Inaba J, Kudo T, Ueda N, Konishi M, Mitsuda N, Takiguchi Y, Kondou Y, Yoshizumi T, Ohme-Takagi M, Matsui M, Yano K, Yanagisawa S, Sakakibara H.

Plant Cell. 2018 Apr;30(4):925-945. doi: 10.1105/tpc.17.00810. Epub 2018 Apr 5.

28.

Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation.

Kamizato K, Marsala S, Navarro M, Kakinohana M, Platoshyn O, Yoshizumi T, Lukacova N, Wancewicz E, Powers B, Mazur C, Marsala M.

Exp Neurol. 2018 Jul;305:66-75. doi: 10.1016/j.expneurol.2018.03.013. Epub 2018 Mar 30.

PMID:
29608917
29.

Selective Gene Delivery for Integrating Exogenous DNA into Plastid and Mitochondrial Genomes Using Peptide-DNA Complexes.

Yoshizumi T, Oikawa K, Chuah JA, Kodama Y, Numata K.

Biomacromolecules. 2018 May 14;19(5):1582-1591. doi: 10.1021/acs.biomac.8b00323. Epub 2018 Apr 5.

30.

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation-The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation.

Yamada Y, Hoshino K, Fuchimoto Y, Matsubara K, Hibi T, Yagi H, Abe Y, Shinoda M, Kitago M, Obara H, Yagi T, Okajima H, Kaido T, Uemoto S, Suzuki T, Kubota K, Yoshizumi T, Maehara Y, Inomata Y, Kitagawa Y, Egawa H, Kuroda T.

Transplant Direct. 2018 Feb 2;4(2):e342. doi: 10.1097/TXD.0000000000000760. eCollection 2018 Feb.

31.

DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1P29S mutation.

Tomino T, Tajiri H, Tatsuguchi T, Shirai T, Oisaki K, Matsunaga S, Sanematsu F, Sakata D, Yoshizumi T, Maehara Y, Kanai M, Cote JF, Fukui Y, Uruno T.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):298-304. doi: 10.1016/j.bbrc.2018.02.073. Epub 2018 Feb 9.

32.

Appropriate Use of Stents to Prevent Biliary Complications after Living Donor Liver Transplantation.

Ikegami T, Yoshizumi T, Soejima Y, Ohira M, Maehara Y.

J Am Coll Surg. 2018 Feb;226(2):201. doi: 10.1016/j.jamcollsurg.2017.10.009. No abstract available.

PMID:
29389377
33.

Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Harimoto N, Yoshizumi T, Fujimoto Y, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2018 Aug;42(8):2606-2616. doi: 10.1007/s00268-018-4493-1.

PMID:
29372372
34.

Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.

Harimoto N, Yugawa K, Ikegami T, Ohira M, Mano Y, Motomura T, Toshima T, Itoh S, Harada N, Soejima Y, Yoshizumi T, Maehara Y, Oda Y.

J Gastroenterol Hepatol. 2018 Jan;33(1):9. doi: 10.1111/jgh.13975. No abstract available.

PMID:
29284078
35.

Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study.

Jeng LB, Lee SG, Soin AS, Lee WC, Suh KS, Joo DJ, Uemoto S, Joh J, Yoshizumi T, Yang HR, Song GW, Lopez P, Kochuparampil J, Sips C, Kaneko S, Levy G.

Am J Transplant. 2018 Jun;18(6):1435-1446. doi: 10.1111/ajt.14623. Epub 2018 Jan 25.

PMID:
29237235
36.

Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.

Motomura T, Yoshizumi T, Ohira M, Mano Y, Toshima T, Itoh S, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Transplant Proc. 2017 Dec;49(10):2409-2410. doi: 10.1016/j.transproceed.2017.09.014.

PMID:
29198692
37.

Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.

Tsukamoto M, Yamashita YI, Imai K, Umezaki N, Yamao T, Okabe H, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Yoshizumi T, Maehara Y, Baba H.

Anticancer Res. 2017 Dec;37(12):6971-6975.

PMID:
29187482
38.

Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats.

Kimura K, Yoshizumi T, Inokuchi S, Itoh S, Motomura T, Mano Y, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Apr;48(5):391-396. doi: 10.1111/hepr.13005. Epub 2018 Jan 8.

PMID:
29168258
39.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
40.

Fibrinolysis in Living Donor Liver Transplantation Recipients Evaluated Using Thromboelastometry: Impact on Mortality.

Shimauchi T, Yamaura K, Higashi M, Abe K, Yoshizumi T, Hoka S.

Transplant Proc. 2017 Nov;49(9):2117-2121. doi: 10.1016/j.transproceed.2017.09.025.

PMID:
29149971
41.

MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection.

Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T, Maehara Y.

Hepatol Res. 2018 Mar;48(4):313-321. doi: 10.1111/hepr.12990. Epub 2017 Dec 5.

PMID:
28984009
42.

Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Takeishi K, Kawanaka H, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y.

World J Surg. 2018 Apr;42(4):1120-1128. doi: 10.1007/s00268-017-4232-z.

PMID:
28920178
43.

Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.

Uchiyama H, Itoh S, Yoshizumi T, Ikegami T, Harimoto N, Soejima Y, Harada N, Morita K, Toshima T, Motomura T, Maehara Y.

HPB (Oxford). 2017 Dec;19(12):1082-1090. doi: 10.1016/j.hpb.2017.08.004. Epub 2017 Sep 7.

PMID:
28888776
44.

Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience.

Ikegami T, Ueda Y, Akamatsu N, Ishiyama K, Goto R, Soyama A, Kuramitsu K, Honda M, Shinoda M, Yoshizumi T, Okajima H, Kitagawa Y, Inomata Y, Ku Y, Eguchi S, Taketomi A, Ohdan H, Kokudo N, Shimada M, Yanaga K, Furukawa H, Uemoto S, Maehara Y.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13109. Epub 2017 Sep 24.

PMID:
28881052
45.

Indication of living donor liver transplantation for septuagenarians from double equipoise theory.

Ikegami T, Yoshizumi T, Ohira M, Harada N, Soejima Y, Maehara Y.

Am J Transplant. 2018 Jan;18(1):278-279. doi: 10.1111/ajt.14446. Epub 2017 Aug 16. No abstract available.

PMID:
28742945
46.

The prevalence of transpancreatic common hepatic artery and coexisting variant anatomy.

Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yoshizumi T, Harimoto N, Ohtsuka T, Nakata K, Honda H.

Clin Anat. 2018 May;31(4):598-604. doi: 10.1002/ca.22957. Epub 2017 Dec 8.

PMID:
28726321
47.

Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection.

Itoh S, Yoshizumi T, Tomino T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Feb;48(3):E155-E161. doi: 10.1111/hepr.12939. Epub 2017 Sep 28.

PMID:
28710825
48.

RLR-mediated antiviral innate immunity requires oxidative phosphorylation activity.

Yoshizumi T, Imamura H, Taku T, Kuroki T, Kawaguchi A, Ishikawa K, Nakada K, Koshiba T.

Sci Rep. 2017 Jul 14;7(1):5379. doi: 10.1038/s41598-017-05808-w.

49.

Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.

Harada N, Yoshizumi T, Yamashita YI, Soejima Y, Ikegami T, Harimoto N, Itoh S, Maehara Y.

Anticancer Res. 2017 Jul;37(7):3763-3769.

PMID:
28668872
50.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Harimoto N, Yoshizumi T, Sakata K, Nagatsu A, Motomura T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2017 Nov;41(11):2805-2812. doi: 10.1007/s00268-017-4097-1.

PMID:
28653142

Supplemental Content

Loading ...
Support Center